DiaSorin S.p.A. (BIT:DIA)
69.74
-1.22 (-1.72%)
Mar 3, 2026, 5:35 PM CET
DiaSorin Employees
DiaSorin had 3,280 employees as of June 30, 2025. The number of employees increased by 9 or 0.28% since the number was reported on December 31, 2024.
Employees
3,280
Change
9
Growth
0.28%
Revenue / Employee
€373,050
Profits / Employee
€56,787
Market Cap
3.76B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 3,280 | 9 | 0.28% | 3,280 | 0 |
| Dec 31, 2024 | 3,271 | 38 | 1.18% | 3,212 | 59 |
| Dec 31, 2023 | 3,233 | -153 | -4.52% | 3,184 | 49 |
| Dec 31, 2022 | 3,386 | 28 | 0.83% | 3,344 | 42 |
| Dec 31, 2021 | 3,358 | 1,292 | 62.54% | 3,313 | 45 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Amplifon | 15,070 |
| GPI S.p.A. | 7,808 |
| Recordati Industria Chimica e Farmaceutica | 4,583 |
| Safilo Group | 3,449 |
| Garofalo Health Care | 2,865 |
| EL.En. | 1,420 |
| Svas Biosana | 350 |
| Talea Group | 240 |
DiaSorin News
- 4 months ago - Invesco International Small-Mid Company Fund Q3 2025 Portfolio Positioning - Seeking Alpha
- 10 months ago - DiaSorin: Anticipate A Double-Digit EBITDA Growth Rate - Seeking Alpha
- 1 year ago - DiaSorin S.p.A. (DSRLF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Italy's DiaSorin ex-Covid revenue in line with guidance - Reuters
- 1 year ago - Diagnostics group DiaSorin's nine-month adjusted core profit up 6% - Reuters
- 1 year ago - DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 years ago - DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Diasorin 2023 revenue drops 14%, in line with guidance; shares fall - Reuters